Ultralytics
Ultralytics Raises $30M in Series A
Ultralytics Raises $30M in Series A
Ultralytics has successfully raised $30M in a Series A led by Elephant VC.
Company Overview
Ultralytics is a AI/ML company headquartered in Los Angeles, CA, founded in 2020 with 50+ employees.
Computer vision AI platform powering object detection for enterprises
Fundraising Details
- Amount Raised: $30M
- Round Type: Series A
- Date: 2025-09-20
- Investors: Elephant VC
About Ultralytics
Computer vision AI platform powering object detection for enterprises The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Los Angeles, CA
- Founded: 2020
- Team Size: 50+
- Industry: AI/ML
What This Means
This funding round demonstrates strong investor confidence in Ultralytics's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Ultralytics's successful fundraising reflects the strong fundamentals and growth potential in this space.
Looking Ahead
With this new capital, Ultralytics is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-09-20. For more information about Ultralytics, visit their headquarters at Los Angeles, CA.
Company Info
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started